Literature DB >> 23312642

Neurogenic lower urinary tract dysfunction.

Jalesh N Panicker1, Marianne De Sèze, Clare J Fowler.   

Abstract

The two roles of the lower urinary tract are storage of urine and emptying at appropriate times. Optimal and coordinated activity of the bladder and urethra is subject to complex neural control which involves all levels of the nervous system, from cortex to peripheral nerve. This explains the high prevalence of urinary disturbances in neurological disease. Information obtained from history taking and supplemented by use of a bladder diary forms the cornerstone of evaluation. Ultrasonography is used to assess the degree of incomplete bladder emptying, and for assessing the upper tracts. Urodynamic tests, with or without simultaneous fluoroscopic monitoring, assess detrusor and bladder outlet function and give fundamental information about detrusor pressure and thus the risk of upper tract damage. Impaired emptying is most often managed by clean-intermittent self-catheterization, which should be initiated if the postvoid residual urine exceeds one-third of bladder capacity or is greater than 100mL, or rarely if spontaneous voiding is dangerous due to high detrusor pressure. Storage symptoms are most often managed using antimuscarinic medications. Intradetrusor injection of botulinum toxin type A is emerging as an effective treatment for managing detrusor overactivity. Understanding of the underlying mechanism of lower urinary tract dysfunction is crucial for effective management.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312642     DOI: 10.1016/B978-0-444-52901-5.00017-4

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  9 in total

Review 1.  Neurogenic lower urinary tract dysfunction: evaluation and management.

Authors:  Katarina Ivana Tudor; Ryuji Sakakibara; Jalesh N Panicker
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 2.  Lower urinary tract dysfunction in common neurological diseases.

Authors:  Mohamad Moussa; Athanasios Papatsoris; Mohamed Abou Chakra; Yousef Fares; Athanasios Dellis
Journal:  Turk J Urol       Date:  2020-04-30

Review 3.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

4.  Early warning model construction and validation for urinary tract infection in patients with neurogenic lower urinary tract dysfunction (NLUTD): a retrospective study.

Authors:  Liqiong Zhou; Surui Liang; Qin Shuai; Chunhua Fan; Linghong Gao; Wenzhi Cai
Journal:  PeerJ       Date:  2022-05-05       Impact factor: 3.061

5.  Initial experience with the treatment of neurogenic detrusor overactivity with a new β-3 agonist (mirabegron) in patients with spinal cord injury.

Authors:  J Wöllner; J Pannek
Journal:  Spinal Cord       Date:  2015-10-27       Impact factor: 2.772

6.  Urogynecological survey in a group of Italian women treated for overactive bladder: Symptoms and quality of life analysis during the Covid-19 period.

Authors:  Michele Carlo Schiavi; Marzio Angelo Zullo; Paolo Luffarelli; Anna Di Pinto; Cosimo Oliva; Pierluigi Palazzetti
Journal:  Taiwan J Obstet Gynecol       Date:  2021-07       Impact factor: 1.705

7.  Long-term outcomes of urinary tract reconstruction in patients with neurogenic urinary tract dysfunction.

Authors:  E U Johnson; Gurpreet Singh
Journal:  Indian J Urol       Date:  2013-10

Review 8.  The role of noninvasive testing and questionnaires in urethroplasty follow-up.

Authors:  Gareth J Warren; Bradley A Erickson
Journal:  Transl Androl Urol       Date:  2014-06

9.  Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study.

Authors:  Vivien Li; Jalesh N Panicker; Collette Haslam; Jeremy Chataway
Journal:  J Neurol       Date:  2020-07-16       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.